中文   |   English   |   Email Alert

Perspective on Nrf2, Epigenomics and Cancer Stem Cells in Cancer Chemoprevention Using Dietary Phytochemicals and Traditional Chinese Medicines

Progress in Chemistry ›› 2013, Vol. 25 ›› Issue (09) : 1526 -1543.

PDF (1783KB)
Progress in Chemistry ›› 2013, Vol. 25 ›› Issue (09) : 1526-1543 DOI: 10.7536/PC130717
Scan to read & Share
Perspective on Nrf2, Epigenomics and Cancer Stem Cells in Cancer Chemoprevention Using Dietary Phytochemicals and Traditional Chinese Medicines
Author information +
History +
PDF (1783KB)

Abstract

Cancer is one of the leading causes of death worldwide. The innovation of modern diagnostics and chemotherapeutics has improved cancer patients' treatment and care, but advanced stages of cancer remain extremely challenging to treat. Therefore, new and creative approaches are needed to prevent and treat cancer. Herbal medicines have been used for many centuries to prevent diseases such as cancer. Funding agencies, such as the National Cancer Institute in the United States, have recently emphasized support for cancer chemoprevention research using natural phytochemicals and non-toxic drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent or delay the onset of cancer. This perspective distills the latest in cancer chemoprevention research using bioactive components from fruits, vegetables, green tea and Traditional Chinese Medicines (TCM), focusing on Nrf2, epigenomic and cancer stem cell effects.

Keywords

cancer chemoprevention / Nrf2 / epigenomics / dietary components / phytochemical / traditional Chinese medicines

Cite this article

Download citation ▾
Zheng-Yuan Su, Limin Shu, Jong Hun Lee, Franciso Fuentes, Hu Wang, Tien-Yuan Wu, Siwang Yu, Ah-Ng Tony Kong. Perspective on Nrf2, Epigenomics and Cancer Stem Cells in Cancer Chemoprevention Using Dietary Phytochemicals and Traditional Chinese Medicines. Progress in Chemistry, 2013, 25(09): 1526-1543 DOI:10.7536/PC130717

登录浏览全文

4963

注册一个新账户 忘记密码

References

PDF (1783KB)

1371

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉